[1] |
CHANG Chen, YANG Liyan, CAI Hongqing, YUAN Qing, HAO Jiajie, WANG Mingrong.
Expressions and clinical implications of SERPINE1 mRNA in esophageal squamous carcinoma tissues
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(4): 245-249.
|
[2] |
DU Qiang, YAO Yiyong, ZENG Gang.
Expression and clinical significance of ASPM in lung adenocarcinoma according to the TCGA database
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 457-463.
|
[3] |
XU Haiming, LIU Keliang, HAO Yanxing, WANG Ling, LIU Zhihong, DE Xiaoming.
Usefulness of combined application of biomarkers in early auxiliary diagnosis of silicosis
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(5): 395-397,401.
|
[4] |
ZHU Yiqing, ZHANG Tongtong, ZHENG Junwen, HAO Jiajie, CAI Yan, WANG Mingrong, LIANG Jianwei, ZHANG Yu.
Expression status of p-mTOR and its prognostic implication in colorectal cancer
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(3): 161-165.
|
[5] |
ZHAO Hua, LU Xue, CAI Tianjing, LI Shuang, TIAN Mei, LIU Qingjie.
Screening for radiation-sensitive biomarkers in rat plasma based on metabolomics studies
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(3): 166-170,176.
|
[6] |
SUN Xiaonan, YUAN Qing, YANG Liyan, ZHANG Yu, CAI Yan, XU Xin, WANG Mingrong, HAO Jiajie, JIA Xuemei.
FGFBP2 over-expresssion promoted cell proliferation in esophageal squamous carcinoma cells
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(3): 180-185,192.
|
[7] |
ZHANG Haiyan, LI Qingye, CHEN Shen, CHEN Wen, HE Zhini.
Construction of an environmental pollution-responsive gene-specific pyrosequencing assay
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2017, 29(2): 81-86.
|
[8] |
ZHENG Jian, LAN Tao, LIU Wei, DENG Rongxia, LI Peimao, ZHANG Yanfang, LIU Jianjun.
Differentially expressed miRNA profile in workers with trichloroethylene-induced medicamentosa-like dermatitis
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2016, 28(6): 468-471.
|
[9] |
Bernd Kaina.
DNA repair in cancer therapy with methylating anticancer drugs: improving therapeutic efficacy and reducing side effects
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2016, 28(5): 333-341,347.
|
[10] |
GAO Zhikui, LIU Ran, YIN Lihong, PU Yuepu.
A case-control study on the risk of esophageal carcinoma and miR-338 cluster
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2016, 28(2): 107-110.
|
[11] |
LI Lin, LI Xiaoxin, LIN Zhongwu, HU Jiangwei, ZHANG Xueqing, SHEN Liping, CHANG Cheng, CHEN Ying, GE Yinlin, WANG Zhidong.
Feasibility study on expression of POLH mRNA as a molecular biomarker for radiation injury
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2015, 27(6): 421-425,431.
|
[12] |
GUO Xia,JIN Hua,Mayila·KAMILIJIANG,LIU Kai-jiang,Axiangu·HASIMU,Halidan·REYIMU,WU Gui-zhen,Abulizi·ABUDULA.
Correlation of the dynamic changes of plasma apoA l content and mTOR activity with cervical carcinogenesis development in Uyghur women
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2014, 26(3): 185-192.
|
[13] |
FENG Jiang-bin, LU Xue, CHEN De-qing, LIU Qing-jie.
Multiple Mitochondrial DNA Deletions Analysis in Lymphoblastoid Cell Line Irradiated by 60Co Gamma Rays
[J]. , 2008, 20(2): 115-118.
|
[14] |
TIAN Ying1,WANG Bin2,YAN Zhi_yong2,LI Na1.
Developing a Serum Proteomic Pattern with SELDI_TOF_MS for Screening Laryngeal Carcinoma
[J]. , 2007, 19(5): 358-361.
|
[15] |
XING Ming-luan, WENG Deng-po, ZHENG Yi-fan, et al.
An Exploration of the Biomarker Related with Antioxidant System: Total Oxidant Scavenging Capacity(TOSC)
[J]. , 2004, 16(5): 263-266.
|